Shattuck Labs Inc Expected to Report a Loss of $0.32 per Share and 40% Revenue Growth in 2024

institutes_icon
PortAI
03-12 04:26
3 sources

Summary

Shattuck Labs Inc is expected to report a loss of 32 cents per share for the period ending December 31, 2024, with quarterly revenue expected to grow by 40% to $999,250. Analysts’ average rating is ‘hold’, and a 12-month median target price is $1.20, slightly below the last closing price of $1.23. Recent quarterly results have shown mixed performance compared to expectations, with earnings estimates remaining unchanged over the past three months. Reuters

Impact Analysis

  1. Business Overview Analysis:
  • Shattuck Labs Inc operates in the biotech sector, focusing on developing immunotherapy treatments. Its core business model involves research and development aimed at producing innovative healthcare solutions, which are a significant revenue stream.
  • The company faces competition from established biotech firms but leverages its unique technology platform for potential competitive advantage.
  • Recent events include improved earnings performance compared to previous quarters, indicating operational advancements despite ongoing losses.
    benzinga_article+ 2
  1. Financial Statement Analysis:
  • Income Statement: The expected revenue growth of 40% is a positive indicator, suggesting successful market penetration or increased product demand. However, the projected per-share loss reflects ongoing challenges in achieving profitability. Past earnings have shown improvements, with a lower-than-expected loss per share of 41 cents compared to analyst projections of 57 cents.
  • Balance Sheet: A detailed evaluation is needed to assess asset quality and liability structure, focusing on cash reserves and debt levels.
  • Cash Flow: Operational cash flow generation might be strained given the ongoing losses, necessitating careful management of investment needs and financing activities.
  • Financial Ratios: Profitability is currently weak due to losses, affecting ROE and ROA negatively. Solvency indicators such as debt/equity ratio and interest coverage need attention to ensure financial stability.
    Reuters+ 3
Event Track